greeksoup/ stocks
Stocks / United States / JNJ / Q2 FY2025

Johnson & Johnson Q2 FY2025 results: revenue $23.7 billion, up 5.8% on the year

Johnson & Johnson (JNJ) reported revenue of $23.7 billion for Q2 FY2025, the quarter ended 29 June 2025, up 5.8% on the same quarter a year earlier. Net income was $5.5 billion, up 18.2% on the year, and diluted earnings per share $2.29. The figures are the company's own, from the 10-Q it filed with the SEC on 24 July 2025.

Revenue$23.7 billionup 5.8%
Net income$5.5 billionup 18.2%
Diluted EPS$2.29
QuarterQ2 FY2025ended 29 June 2025

The quarter, against the one before and a year earlier

LineQ2 FY2025Q1 FY2025Q2 FY2024Change on the year
Revenue23,74321,89322,447+5.8%
Cost of revenue7,6287,3576,869+11.0%
Gross profit16,11514,53615,578+3.4%
Gross margin67.9%66.4%69.4%
Research and development3,5163,2253,440+2.2%
Selling, general and administrative5,8895,1125,681+3.7%
Interest expense308204270+14.1%
Pre-tax income6,49113,6315,748+12.9%
Income tax9542,6321,062-10.2%
Effective tax rate14.7%19.3%18.5%
Net income5,53710,9994,686+18.2%
Net margin23.3%50.2%20.9%
Diluted EPS$2.29$4.54$1.93+18.7%

$ million except per share. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2025Q1 FY2025Q2 FY2024Change on the year
Operating cash flow3,8784,1745,633-31.2%
Capital expenditure1,043795976+6.9%
Free cash flow2,8353,3794,657-39.1%
Free cash flow margin11.9%15.4%20.7%
Depreciation and amortisation1,9431,7721,782+9.0%
Share-based compensation410288341+20.2%
Buybacks0.02,127136n/a
Dividend per share$1.30$1.24$1.24+4.8%
Diluted shares, weighted2,419m2,424m2,422m-0.1%
Shares outstanding at period end2,408m2,406m2,407m+0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2025Q1 FY2025Q2 FY2024Change on the year
Total assets193,389193,671181,088+6.8%
Cash and equivalents18,57738,47424,878-25.3%
Receivables17,84616,02015,794+13.0%
Inventory13,41212,65912,169+10.2%
Goodwill48,11744,46844,250+8.7%
Long-term debt39,23538,35531,636+24.0%
Shareholders' equity78,47378,10971,538+9.7%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue21,35121,39521,38322,44722,47122,52021,89323,74323,99324,56424,06225,310
Cost of revenue6,6063,3406,5116,8696,9637,1287,3577,6287,3037,9688,1068,051
Gross profit14,74514,59714,87215,57815,50815,39214,53616,11516,69016,59615,95617,259
Gross margin69%68%70%69%69%68%66%68%70%68%66%68%
R&D3,4474,2463,5423,4404,9525,2983,2253,5163,6724,2523,5273,653
SG&A5,4003,3095,2575,6815,4786,4535,1125,8895,9226,7536,0346,432
Interest expense19219.0155270193137204308245214272281
Pre-tax income5,2174,8263,7145,7483,3383,88713,6316,4917,4934,9665,9906,747
Tax rate17%-3%12%18%19%12%19%15%31%-3%13%18%
Net income26,0284,0493,2554,6862,6943,43110,9995,5375,1525,1165,2355,534
Net margin122%19%15%21%12%15%50%23%21%21%22%22%
Diluted EPS$10.21$1.67$1.34$1.93$1.11$1.41$4.54$2.29$2.12$2.08$2.14$2.27
Operating cash flow7,4897,8633,6575,6337,9936,9834,1743,8789,1697,3092,5148,616
Capital expenditure9671,5898079761,0291,6127951,0431,1571,8371,0491,321
Free cash flow6,5226,2742,8504,6576,9645,3713,3792,8358,0125,4721,4657,295
Buybacks9202161,4751365392822,1270.01,9021,9244,028221
Shares outstanding2,407m2,409m2,407m2,407m2,408m2,408m2,406m2,408m2,409m2,410m2,407m2,410m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 29 June 2025, filed 24 July 2025, accession 0000200406-25-000178: the filing on EDGAR. All of Johnson & Johnson's filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install